AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 295: G552-G558, 2008. First published June 26, 2008; doi:10.1152/ajpgi.90278.2008
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/3/G552    most recent
ajpgi.90278.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zyromski, N. J.
Right arrow Articles by Swartz-Basile, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zyromski, N. J.
Right arrow Articles by Swartz-Basile, D. A.

INFLAMMATION/IMMUNITY/MEDIATORS

A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis

Nicholas J. Zyromski, Abhishek Mathur, Henry A. Pitt, Debao Lu, John T. Gripe, Julia J. Walker, Kyle Yancey, Terence E. Wade, and Deborah A. Swartz-Basile

Department of Surgery, Indiana University School of Medicine

Submitted 3 April 2008 ; accepted in final form 19 June 2008

Obesity is clearly an independent risk factor for increased severity of acute pancreatitis (AP), although the mechanisms underlying this association are unknown. Adipokines (including leptin and adiponectin) are pleiotropic molecules produced by adipocytes that are important regulators of the inflammatory response. We hypothesized that the altered adipokine milieu observed in obesity contributes to the increased severity of pancreatitis. Lean (C57BL/6J), obese leptin-deficient (LepOb), and obese hyperleptinemic (LepDb) mice were subjected to AP by six hourly intraperitoneal injections of cerulein (50 µg/kg). Severity of AP was assessed by histology and by measuring pancreatic concentration of the proinflammatory cytokines IL-1β and IL-6, the chemokine MCP-1, and the marker of neutrophil activation MPO. Both congenitally obese strains of mice developed significantly more severe AP than wild-type lean animals. Severity of AP was not solely related to adipose tissue volume: LepOb mice were heaviest; however, LepDb mice developed the most severe AP both histologically and biochemically. Circulating adiponectin concentrations inversely mirrored the severity of pancreatitis. These data demonstrate that congenitally obese mice develop more severe AP than lean animals when challenged by cerulein hyperstimulation and suggest that alteration of the adipokine milieu exacerbates the severity of AP in obesity.

adiponectin; leptin



Address for reprint requests and other correspondence: N. J. Zyromski, Dept. of Surgery, Indiana Univ. School of Medicine, 535 Barnhill Dr., RT 130, Indianapolis, IN 46202 (e-mail: nzyromsk{at}iupui.edu)




This article has been cited by other articles:


Home page
GutHome page
A. Schaffler and J. Scholmerich
The role of adiponectin in inflammatory gastrointestinal diseases
Gut, March 1, 2009; 58(3): 317 - 322.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.